Course Overview

As the incidence of melanoma rises, so do the challenges of managing its advanced stages. This immersive CME webinar delves into the promise of cutting-edge therapies like dual LAG-3/PD-1 checkpoint blockade regimens over conventional therapies with severe limitations. These new therapies are transforming the landscape of metastatic melanoma treatment. Watch now to elevate your decision-making and gain insights into the latest breakthroughs that are reshaping the future of patient care.

Key topics:
  • Evaluate Dual LAG-3/PD-1 Checkpoint Blockade Regimens: Uncover the mechanism behind the combined therapy's efficacy and its role in improving patient outcomes
  • Assess Efficacy and Safety: Master the art of discerning the most effective and safest treatment strategies for your patients, backed by the latest clinical data.
  • Stay Ahead of the Curve: Stay informed about the latest clinical trials, advancements, and approvals that are reshaping the future of melanoma care.
Omid Hamid
Omid Hamid, MD

Chief, Translational Research & Immuno-Oncology​
Co-Director, Cutaneous Malignancies ​
The Angeles Clinic & Research Institute, a Cedars Sinai Affiliate​
Professor, Department of Medicine – Cedars Sinai Medical Center​
Los Angeles, CA